According to one forecast, the stem cell market will grow at an annual rate of 9.2% and attain a value of almost $16 billion by 2025. This prediction, from a 2017 study by Grand View Research, may not ...
Manufacturing is the key to the vast potential of stem cells. And the manufacturing operations of Orange County’s most prominent entry in the field are expected to remain here after its sale to a ...
CHICAGO, July 26, 2023 /PRNewswire/ -- In the near future, the stem cell manufacturing industry is poised to experience unprecedented growth and innovation, revolutionizing healthcare and regenerative ...
News-Medical.Net on MSN
Cellares to expand automated manufacturing to gene-edited stem cell therapies
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford ...
Cellares is partnering with Stanford Medicine to automate gene-edited stem cell therapy for HIV and more than 19 rare diseases.
Scientists are using artificial intelligence to ensure stem cells are good enough for patients, potentially breaking a bottleneck in making these regenerative medicines commercially available to ...
Cellares will establish a standardized platform manufacturing process on the Cell Shuttle and platform release assays on the Cell Q.
Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...
NEWPORT BEACH, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Elevai Labs, Inc. (ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce it has signed an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results